What is the prevalence of genetically defined skeletal muscle channelopathies in England?
This study provides the first overall prevalence data for genetically defined skeletal muscle channelopathies in England, highlighting that a few mutations account for most cases.
We describe for the first time the overall prevalence of genetically defined skeletal muscle channelopathies in England. Despite the large variety of mutations observed in patients with nondystrophic myotonia and ATS, a limited number accounted for a large proportion of cases.
Horga et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: